Register
Medicines reference
Product

Baytril

Enrofloxacin · Elanco GmbH, Elanco US Inc.

9 forms: scored tablet, solution, tablet. No registration in force in Georgia.

Forms and doses0 of 9 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Choose species and weight; the matching row will be highlighted.
Form Species Dose Frequency Georgia
15 mg, Tablet · Cat Cat Susceptible bacterial infections in dogs and cats · By mouth: 5 mg/kg once daily or split into two doses, for 3-10 days Georgia No
15 mg, Tablet · Dog Dog Susceptible bacterial infections in dogs and cats · By mouth: 5 mg/kg once daily or split into two doses, for 3-10 days Georgia No
Details: pack, label wording, sources, registration

Baytril 15 mg, Tablet

Flavour tablet, enrofloxacin 15 mg, for cats and dogs
Composition / strength
Formulation Type
Tablet
Administration route
By mouth
Manufacturer
Registration
Georgia No
UK Yes, veterinary
№ Vm 52127/5137
Verified on: 29 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
Cat
WeightSusceptible bacterial infections in dogs and cats · By mouth
Any weight 5 mg/kg
  • Susceptible bacterial infections in dogs and cats · By mouth (once daily or split into two doses, for 3-10 days): Enrofloxacin 5 mg/kg/day PO, with or without food: one 15 mg tablet per 3 kg body weight daily. Do not exceed the recommended dose: in cats retinotoxic effects including blindness can occur when it is exceeded. Not recommended in cats under 8 weeks; not for prophylaxis. Treatment may be started with Baytril 2.5% or 5% injection and continued with the tablets.
Source:
VMD SPC 2025
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Baytril Flavour Tablets 15 mg - Summary of Product Characteristics
UK Veterinary Medicines Directorate, Product Information Database, 2025
Dog
WeightSusceptible bacterial infections in dogs and cats · By mouth
Any weight 5 mg/kg
  • Susceptible bacterial infections in dogs and cats · By mouth (once daily or split into two doses, for 3-10 days): Enrofloxacin 5 mg/kg/day PO for small dogs: one 15 mg tablet per 3 kg body weight daily. Not for dogs under 1 year of age, or exceptionally large breeds with a longer growth period under 18 months (articular cartilage). Not for prophylaxis.
Source:
VMD SPC 2025
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Baytril Flavour Tablets 15 mg - Summary of Product Characteristics
UK Veterinary Medicines Directorate, Product Information Database, 2025
22.7 mg, Scored tablet · Cat Cat Susceptible bacterial infections in dogs and cats · By mouth: 5 mg/kg once daily or two equal doses 12 hours apart, up to 30 days Georgia No
22.7 mg, Scored tablet · Dog Dog Susceptible bacterial infections in dogs and cats · By mouth: 5–20 mg/kg once daily or two equal doses 12 hours apart, up to 30 days Georgia No
Details: pack, label wording, sources, registration

Baytril 22.7 mg, Scored tablet

Taste Tabs scored tablet, enrofloxacin 22.7 mg, for dogs and cats
Composition / strength
Enrofloxacin22.7 mg
Formulation Type
Scored tablet
Administration route
By mouth
Manufacturer
Registration
Georgia No
US Yes, veterinary
№ NADA 140-441
Verified on: 29 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
Cat
WeightSusceptible bacterial infections in dogs and cats · By mouth
Any weight 5 mg/kg
  • Susceptible bacterial infections in dogs and cats · By mouth (once daily or two equal doses 12 hours apart, up to 30 days): Enrofloxacin 5 mg/kg/day PO, continued 2-3 days beyond the end of clinical signs; do not exceed 5 mg/kg of body weight per day in cats (retinal toxicity). Label chart: 2.27 kg, half a 22.7 mg tablet; 4.5 kg, one 22.7 mg tablet; 6.8 kg, one and a half 22.7 mg tablets or half a 68 mg tablet. Safety in breeding or pregnant cats has not been established.
Source:
FDA 2026
Official product label (SPC), FDA, US
Approved by the US Food and Drug Administration (FDA) as part of the product's authorisation. It applies to that product as authorised there.
Baytril (enrofloxacin) Taste Tabs - FDA-approved animal drug label, NADA 140-441
US Food and Drug Administration, via DailyMed, 2026
Dog
WeightSusceptible bacterial infections in dogs and cats · By mouth
Any weight 5–20 mg/kg
  • Susceptible bacterial infections in dogs and cats · By mouth (once daily or two equal doses 12 hours apart, up to 30 days): Enrofloxacin 5-20 mg/kg/day PO; continue 2-3 days beyond the end of clinical signs. Choose within the range by clinical experience, severity and susceptibility, and monitor dogs on the upper end for inappetence, depression and vomiting. The tablets are double scored; the label chart uses halves. Reassess if there is no improvement within 5 days.
Source:
FDA 2026
Official product label (SPC), FDA, US
Approved by the US Food and Drug Administration (FDA) as part of the product's authorisation. It applies to that product as authorised there.
Baytril (enrofloxacin) Taste Tabs - FDA-approved animal drug label, NADA 140-441
US Food and Drug Administration, via DailyMed, 2026
22.7 mg/ml, Solution · Cat Cat Susceptible bacterial infections in dogs and cats · Intramuscular: No dose for this species - Georgia No
22.7 mg/ml, Solution · Dog Dog Susceptible bacterial infections in dogs and cats · Intramuscular: 2.5 mg/kg single initial IM dose; tablets 12 hours later Georgia No
Details: pack, label wording, sources, registration

Baytril 22.7 mg/ml, Solution

enrofloxacin, solution for injection for dogs
Composition / strength
Enrofloxacin22.7 mg/ml
Formulation Type
Solution
Administration route
Intramuscular
Manufacturer
Registration
Georgia No
US Yes, veterinary
№ NADA 140-913
Verified on: 29 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
Cat
WeightSusceptible bacterial infections in dogs and cats · Intramuscular
Any weight No dose for this species
  • Susceptible bacterial infections in dogs and cats · Intramuscular: No cat dose: this injection is labelled for dogs only, and the label warns that its use in cats may result in retinal toxicity.
Source:
FDA label
Official product label (SPC), FDA, US
Approved by the US Food and Drug Administration (FDA) as part of the product's authorisation. It applies to that product as authorised there.
Baytril (enrofloxacin) Antibacterial Injectable Solution 22.7 mg/mL, for dogs only - FDA-approved label, NADA 140-913
DailyMed, U.S. National Library of Medicine, 2026
Dog
WeightSusceptible bacterial infections in dogs and cats · Intramuscular
Any weight 2.5 mg/kg
  • Susceptible bacterial infections in dogs and cats · Intramuscular (single initial IM dose; tablets 12 hours later): Enrofloxacin 2.5 mg/kg IM as a single initial dose (about 0.11 ml/kg), followed 12 hours later by Baytril tablet therapy. For dogs only.
Source:
FDA label
Official product label (SPC), FDA, US
Approved by the US Food and Drug Administration (FDA) as part of the product's authorisation. It applies to that product as authorised there.
Baytril (enrofloxacin) Antibacterial Injectable Solution 22.7 mg/mL, for dogs only - FDA-approved label, NADA 140-913
DailyMed, U.S. National Library of Medicine, 2026
25 mg/ml (2.5%), Solution · Cat Cat Susceptible bacterial infections in dogs and cats · Subcutaneous: 5 mg/kg once daily SC, for up to 5 days Georgia No
25 mg/ml (2.5%), Solution · Dog Dog Susceptible bacterial infections in dogs and cats · Subcutaneous: 5 mg/kg once daily SC, for up to 5 days Georgia No
Details: pack, label wording, sources, registration

Baytril 25 mg/ml (2.5%), Solution

enrofloxacin, solution for injection for dogs and cats
Composition / strength
Enrofloxacin25 mg/ml
Formulation Type
Solution
Administration route
Subcutaneous, Intramuscular
Manufacturer
Registration
Georgia No
UK Yes, veterinary
№ Vm 52127/5119
Verified on: 29 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
Cat
WeightSusceptible bacterial infections in dogs and cats · Subcutaneous
Any weight 5 mg/kg
  • Susceptible bacterial infections in dogs and cats · Subcutaneous (once daily SC, for up to 5 days): Enrofloxacin 5 mg/kg = 1 ml per 5 kg body weight SC once daily for up to 5 days. Do not exceed the dose: retinotoxic effects including blindness can occur in cats. Not in cats under 8 weeks.
Source:
VMD SPC 2026
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Baytril 25 mg/ml Solution for Injection - Summary of Product Characteristics
UK Veterinary Medicines Directorate, Product Information Database, 2026
Dog
WeightSusceptible bacterial infections in dogs and cats · Subcutaneous
Any weight 5 mg/kg
  • Susceptible bacterial infections in dogs and cats · Subcutaneous (once daily SC, for up to 5 days): Enrofloxacin 5 mg/kg = 1 ml per 5 kg body weight SC once daily for up to 5 days; repeated injections at different sites. May be continued with enrofloxacin tablets. Not in small breeds under 8 months, large breeds under 12 months or giant breeds under 18 months; not with seizure disorders.
Source:
VMD SPC 2026
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Baytril 25 mg/ml Solution for Injection - Summary of Product Characteristics
UK Veterinary Medicines Directorate, Product Information Database, 2026
50 mg, Tablet · Cat Cat Susceptible bacterial infections in dogs and cats · By mouth: No dose for this species - Georgia No
50 mg, Tablet · Dog Dog Susceptible bacterial infections in dogs and cats · By mouth: 5 mg/kg once daily or split into two doses, for 3-10 days Georgia No
Details: pack, label wording, sources, registration

Baytril 50 mg, Tablet

Flavour tablet, enrofloxacin 50 mg, for dogs
Composition / strength
Formulation Type
Tablet
Administration route
By mouth
Manufacturer
Registration
Georgia No
UK Yes, veterinary
№ Vm 52127/5139
Verified on: 29 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
Cat
WeightSusceptible bacterial infections in dogs and cats · By mouth
Any weight No dose for this species
  • Susceptible bacterial infections in dogs and cats · By mouth: No cat dose: this tablet strength is labelled for dogs only. The cat-labelled UK Baytril tablet is Baytril Flavour 15 mg (one tablet per 3 kg).
Source:
VMD SPC
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Baytril Flavour Tablets 50 mg - Summary of Product Characteristics
UK Veterinary Medicines Directorate, Product Information Database, 2025
Dog
WeightSusceptible bacterial infections in dogs and cats · By mouth
Any weight 5 mg/kg
  • Susceptible bacterial infections in dogs and cats · By mouth (once daily or split into two doses, for 3-10 days): Enrofloxacin 5 mg/kg/day PO for medium dogs: one 50 mg tablet per 10 kg body weight daily. Not for dogs under 1 year of age, or exceptionally large breeds with a longer growth period under 18 months (articular cartilage). Not for prophylaxis.
Source:
VMD SPC
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Baytril Flavour Tablets 50 mg - Summary of Product Characteristics
UK Veterinary Medicines Directorate, Product Information Database, 2025
50 mg/ml (5%), Solution · Cat Cat Susceptible bacterial infections in dogs and cats · Subcutaneous: 5 mg/kg once daily SC, for up to 5 days Georgia No
50 mg/ml (5%), Solution · Dog Dog Susceptible bacterial infections in dogs and cats · Subcutaneous: 5 mg/kg once daily SC, for up to 5 days Georgia No
Details: pack, label wording, sources, registration

Baytril 50 mg/ml (5%), Solution

enrofloxacin, solution for injection for dogs and cats
Composition / strength
Enrofloxacin50 mg/ml
Formulation Type
Solution
Administration route
Subcutaneous, Intramuscular, Intravenous
Manufacturer
Registration
Georgia No
UK Yes, veterinary
№ Vm 52127/5120
Verified on: 29 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
Cat
WeightSusceptible bacterial infections in dogs and cats · Subcutaneous
Any weight 5 mg/kg
  • Susceptible bacterial infections in dogs and cats · Subcutaneous (once daily SC, for up to 5 days): Enrofloxacin 5 mg/kg = 1 ml per 10 kg body weight SC once daily for up to 5 days. Do not exceed the dose: retinotoxic effects including blindness can occur in cats. Not in cats under 8 weeks.
Source:
VMD SPC
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Baytril 50 mg/ml Solution for Injection - Summary of Product Characteristics
UK Veterinary Medicines Directorate, Product Information Database, 2026
Dog
WeightSusceptible bacterial infections in dogs and cats · Subcutaneous
Any weight 5 mg/kg
  • Susceptible bacterial infections in dogs and cats · Subcutaneous (once daily SC, for up to 5 days): Enrofloxacin 5 mg/kg = 1 ml per 10 kg body weight SC once daily for up to 5 days. May be continued with enrofloxacin tablets. Not in small breeds under 8 months, large breeds under 12 months or giant breeds under 18 months; not with seizure disorders.
Source:
VMD SPC
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Baytril 50 mg/ml Solution for Injection - Summary of Product Characteristics
UK Veterinary Medicines Directorate, Product Information Database, 2026
68 mg, Scored tablet · Cat Cat Susceptible bacterial infections in dogs and cats · By mouth: 5 mg/kg once daily or two equal doses 12 hours apart, up to 30 days Georgia No
68 mg, Scored tablet · Dog Dog Susceptible bacterial infections in dogs and cats · By mouth: 5–20 mg/kg once daily or two equal doses 12 hours apart, up to 30 days Georgia No
Details: pack, label wording, sources, registration

Baytril 68 mg, Scored tablet

Taste Tabs scored tablet, enrofloxacin 68 mg, for dogs and cats
Composition / strength
Formulation Type
Scored tablet
Administration route
By mouth
Manufacturer
Registration
Georgia No
US Yes, veterinary
№ NADA 140-441
Verified on: 29 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
Cat
WeightSusceptible bacterial infections in dogs and cats · By mouth
Any weight 5 mg/kg
  • Susceptible bacterial infections in dogs and cats · By mouth (once daily or two equal doses 12 hours apart, up to 30 days): Enrofloxacin 5 mg/kg/day PO, continued 2-3 days beyond the end of clinical signs; do not exceed 5 mg/kg of body weight per day in cats (retinal toxicity). On the label chart half a 68 mg tablet is the step for a 6.8 kg cat. Safety in breeding or pregnant cats has not been established.
Source:
FDA 2026
Official product label (SPC), FDA, US
Approved by the US Food and Drug Administration (FDA) as part of the product's authorisation. It applies to that product as authorised there.
Baytril (enrofloxacin) Taste Tabs - FDA-approved animal drug label, NADA 140-441
US Food and Drug Administration, via DailyMed, 2026
Dog
WeightSusceptible bacterial infections in dogs and cats · By mouth
Any weight 5–20 mg/kg
  • Susceptible bacterial infections in dogs and cats · By mouth (once daily or two equal doses 12 hours apart, up to 30 days): Enrofloxacin 5-20 mg/kg/day PO; continue 2-3 days beyond the end of clinical signs. Choose within the range by clinical experience, severity and susceptibility, and monitor dogs on the upper end for inappetence, depression and vomiting. The tablets are double scored; the label chart uses halves. Reassess if there is no improvement within 5 days.
Source:
FDA 2026
Official product label (SPC), FDA, US
Approved by the US Food and Drug Administration (FDA) as part of the product's authorisation. It applies to that product as authorised there.
Baytril (enrofloxacin) Taste Tabs - FDA-approved animal drug label, NADA 140-441
US Food and Drug Administration, via DailyMed, 2026
136 mg, Scored tablet · Cat Cat Susceptible bacterial infections in dogs and cats · By mouth: 5 mg/kg once daily or two equal doses 12 hours apart, up to 30 days Georgia No
136 mg, Scored tablet · Dog Dog Susceptible bacterial infections in dogs and cats · By mouth: 5–20 mg/kg once daily or two equal doses 12 hours apart, up to 30 days Georgia No
Details: pack, label wording, sources, registration

Baytril 136 mg, Scored tablet

Taste Tabs scored tablet, enrofloxacin 136 mg, for dogs and cats
Composition / strength
Enrofloxacin136 mg
Formulation Type
Scored tablet
Administration route
By mouth
Manufacturer
Registration
Georgia No
US Yes, veterinary
№ NADA 140-441
Verified on: 29 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
Cat
WeightSusceptible bacterial infections in dogs and cats · By mouth
Any weight 5 mg/kg
  • Susceptible bacterial infections in dogs and cats · By mouth (once daily or two equal doses 12 hours apart, up to 30 days): Enrofloxacin 5 mg/kg/day PO, continued 2-3 days beyond the end of clinical signs; do not exceed 5 mg/kg of body weight per day in cats (retinal toxicity). The label cat chart uses the 22.7 mg and 68 mg tablets; a 136 mg tablet fits only cats of about 13.6 kg per half tablet. Safety in breeding or pregnant cats has not been established.
Source:
FDA 2026
Official product label (SPC), FDA, US
Approved by the US Food and Drug Administration (FDA) as part of the product's authorisation. It applies to that product as authorised there.
Baytril (enrofloxacin) Taste Tabs - FDA-approved animal drug label, NADA 140-441
US Food and Drug Administration, via DailyMed, 2026
Dog
WeightSusceptible bacterial infections in dogs and cats · By mouth
Any weight 5–20 mg/kg
  • Susceptible bacterial infections in dogs and cats · By mouth (once daily or two equal doses 12 hours apart, up to 30 days): Enrofloxacin 5-20 mg/kg/day PO; continue 2-3 days beyond the end of clinical signs. Choose within the range by clinical experience, severity and susceptibility, and monitor dogs on the upper end for inappetence, depression and vomiting. Label chart for a 27.2 kg dog: one 136 mg tablet at 5 mg/kg, two at 10, three at 15, four at 20 mg/kg. Reassess if there is no improvement within 5 days.
Source:
FDA 2026
Official product label (SPC), FDA, US
Approved by the US Food and Drug Administration (FDA) as part of the product's authorisation. It applies to that product as authorised there.
Baytril (enrofloxacin) Taste Tabs - FDA-approved animal drug label, NADA 140-441
US Food and Drug Administration, via DailyMed, 2026
150 mg, Tablet · Cat Cat Susceptible bacterial infections in dogs and cats · By mouth: No dose for this species - Georgia No
150 mg, Tablet · Dog Dog Susceptible bacterial infections in dogs and cats · By mouth: 5 mg/kg once daily or split into two doses, for 3-10 days Georgia No
Details: pack, label wording, sources, registration

Baytril 150 mg, Tablet

Flavour tablet, enrofloxacin 150 mg, for dogs
Composition / strength
Enrofloxacin150 mg
Formulation Type
Tablet
Administration route
By mouth
Manufacturer
Registration
Georgia No
UK Yes, veterinary
№ Vm 52127/5138
Verified on: 29 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
Cat
WeightSusceptible bacterial infections in dogs and cats · By mouth
Any weight No dose for this species
  • Susceptible bacterial infections in dogs and cats · By mouth: No cat dose: this tablet strength is labelled for dogs only. The cat-labelled UK Baytril tablet is Baytril Flavour 15 mg (one tablet per 3 kg).
Source:
VMD SPC
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Baytril Flavour Tablets 150 mg - Summary of Product Characteristics
UK Veterinary Medicines Directorate, Product Information Database, 2025
Dog
WeightSusceptible bacterial infections in dogs and cats · By mouth
Any weight 5 mg/kg
  • Susceptible bacterial infections in dogs and cats · By mouth (once daily or split into two doses, for 3-10 days): Enrofloxacin 5 mg/kg/day PO for large dogs: one 150 mg tablet per 30 kg body weight daily. Not for dogs under 1 year of age, or exceptionally large breeds with a longer growth period under 18 months (articular cartilage). Not for prophylaxis.
Source:
VMD SPC
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Baytril Flavour Tablets 150 mg - Summary of Product Characteristics
UK Veterinary Medicines Directorate, Product Information Database, 2025
Active substance doses, with sources
Active substance Enrofloxacin
Dose calculatorCalculates the active-substance amount; it is not a prescription.
PatientSpecies and weight will be filled in automatically in other calculators.
Selected dose
Dose Species Indication Route Frequency Source
5 mg/kg Dog, Cat Bacterial Infection; Urinary Tract Infection; Skin and Soft Tissue Infection By mouth / Subcutaneous once daily
VMD SPC 2025
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Baytril Flavour Tablets 15 mg - Summary of Product Characteristics
UK Veterinary Medicines Directorate, Product Information Database, 2025
VMD SPC 2025
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Xeden 150 mg tablet for dogs - Summary of Product Characteristics
UK Veterinary Medicines Directorate, Product Information Database, 2025
VMD SPC 2026
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Baytril 25 mg/ml Solution for Injection - Summary of Product Characteristics
UK Veterinary Medicines Directorate, Product Information Database, 2026
VMD SPC 2026
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Enrocat Flavour 25 mg/ml Oral Suspension for Cats - Summary of Product Characteristics
UK Veterinary Medicines Directorate, Product Information Database, 2026
FDA 2026
Official product label (SPC), FDA, US
Approved by the US Food and Drug Administration (FDA) as part of the product's authorisation. It applies to that product as authorised there.
Baytril (enrofloxacin) Taste Tabs - FDA-approved animal drug label, NADA 140-441
US Food and Drug Administration, via DailyMed, 2026
5–20 mg/kg Dog Bacterial Infection By mouth once daily
FDA 2026
Official product label (SPC), FDA, US
Approved by the US Food and Drug Administration (FDA) as part of the product's authorisation. It applies to that product as authorised there.
Baytril (enrofloxacin) Taste Tabs - FDA-approved animal drug label, NADA 140-441
US Food and Drug Administration, via DailyMed, 2026
10–20 mg/kg Dog Skin and Soft Tissue Infection By mouth once daily
ISCAID 2025
Guideline or consensus statement
Recommendations agreed by a panel of veterinary specialists after reviewing the evidence. They guide practice and do not authorise a product.
Antimicrobial use guidelines for canine pyoderma by the International Society for Companion Animal Infectious Diseases (ISCAID)
Veterinary Dermatology, 2025

Known Contraindications

  • Critical
    Do not use enrofloxacin in animals with epilepsy, seizures, or seizure disorders associated with the central nervous system, because it may stimulate the CNS.
    Sources: VMD SPC · VMD · FDA
  • Critical
    Do not use in animals hypersensitive to the active substance, another fluoroquinolone, or any excipient. Do not use against known quinolone resistance because cross-resistance is extensive. Treat Pseudomonas infections only after susceptibility testing.
    Sources: VMD SPC · VMD
  • Warning
    Elimination may be delayed in animals with pre-existing renal damage. Use with caution in severe renal or hepatic impairment.
    Sources: VMD SPC · VMD
  • Warning
    Use with caution in severe hepatic impairment. Concomitant administration with other hepatically metabolized medicines may reduce clearance of both the quinolone and the other medicine.
    Sources: VMD SPC · VMD · FDA
  • Warning
    The use is not recommended during pregnancy The safety of the veterinary medicinal product has not been established during pregnancy and lactation Safety in breeding or pregnant cats has not been established The veterinary medicinal product may be used safely in pregnant and lactating animals
    Sources: VMD · FDA
  • Warning
    the use is not recommended during lactation may be used safely in pregnant and lactating animals
    Sources: VMD
  • Warning (Dog)
    Not for use in dogs less than 1 year of age, or in exceptionally large breeds with a longer growth period under 18 months of age (Baytril tablets, VMD). The limit differs by product: Baytril injection, small breeds under 8 months, large under 12 months, giant under 18 months; Xeden, under 12 months (small breeds) or 18 months (large breeds); FDA, contraindicated in small and medium breeds aged 2 to 8 months. Use the limit of your product; the reason is cartilage damage during growth.
    Sources: VMD · FDA
  • Warning (Cat)
    Overdose risk: in rare instances, use of enrofloxacin in cats has been associated with retinal toxicity. Do not exceed 5 mg/kg of body weight per day in cats (FDA). From 20 mg/kg: mydriasis, retinal degeneration and loss of vision. Mydriasis may be an indication of impending or existing retinal changes: if the pupils dilate during treatment, stop and examine the eyes.
    Sources: FDA
  • Warning (Cat)
    Minimum age differs by product. Some labels prohibit use in kittens younger than 8 weeks; others prohibit use below 3 months of age or below 1 kg because of cartilage injury risk. Use the limit stated for the specific product; the most conservative limit is 3 months and 1 kg.
    Sources: FDA

Known Drug Interactions

  • Major warning Enrofloxacin + Aminophylline
    Theophylline metabolism is inhibited by erythromycin, cimetidine, propranolol, enrofloxacin, and marbofloxacin
    Recommendation: Reduce the aminophylline dose during concomitant use. Signs of toxicity include vomiting, excitation, tachyarrhythmia, and seizures.
    Sources: MSD Vet Manual
  • Major warning Enrofloxacin + Doxycycline
    Do not combine enrofloxacin with antimicrobials that act antagonistically to quinolones, including macrolides, tetracyclines such as doxycycline, and phenicols such as chloramphenicol.
    Recommendation: Do not administer concurrently. Based on susceptibility testing, choose either a bactericidal fluoroquinolone or a bacteriostatic tetracycline.
    Sources: VMD SPC · VMD
  • Major warning Enrofloxacin + Theophylline
    Do not use concurrently with theophylline as the elimination of theophylline may be delayed Concomitant administration of theophylline requires careful monitoring as serum levels of theophylline may increase
    Recommendation: Avoid the combination where possible. If concomitant use is unavoidable, monitor serum theophylline and be prepared to reduce its dose.
    Sources: VMD
  • Minor warning Enrofloxacin + Sucralfate
    The concomitant administration of substances containing magnesium or aluminium may reduce the absorption of enrofloxacin. These drugs should be administered two hours apart.
    Recommendation: Separation is not critical in dogs, but a 2-hour interval is safe and label-consistent. No comparable measurement exists in cats; use a 2-hour interval in cats.
    Sources: VMD SPC · VMD · JVIM

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.